Search Results 201-210 of 17336 for hba1c

  1. Mayo Clinic

    This content does not have an English version. This content does not have an Arabic version. Skip to content. Mayo Clinic Home Page · Request appointment.

  2. Diabetic Retinopathy And Changes In Lipid Metabolism (Protocol AFA) - Mayo Clinic

    ... HbA1c levels < 5.7 as confirmed by the central laboratory, must meet none of the exclusion criteria listed below, and must have no evidence of retinal ...

  3. A Study of the Effect of Estrogen-Based Contraceptive Therapy on Total and Free Serum Cortisol Levels in Healthy Women - Mayo Clinic

    Poorly controlled diabetes mellitus defined as HbA1c >7.5%,; Use of exogenous glucocorticoid medication or Megace within the last 12 months; Adrenal ...

  4. A Study to Compare Model Predictive Control (MPC) Artificial Pancreas vs. Sensor Augmented Pump (SAP)/Predictive Low Glucose Suspend (PLGS) with Different Stress Assessments for Type 1 Diabetes Patients - Mayo Clinic

    HbA1c < 10.5%, as performed by point of care or central 513 laboratory testing. A1c will be 514 assessed at the screening visit, or if already completed ...

  5. Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery - Mayo Clinic

    HbA1c =< 7%. Women must not be pregnant or breast-feeding; all females of childbearing potential must have a blood test or urine study within 7 days of ...

  6. A Phase 2b, Study Of Linsitinib In Subjects With Active, Moderate To Severe Thyroid Eye Disease (TED) - Mayo Clinic

    Diabetic subjects must have HbA1c < 9.0%. Type 2 diabetic subjects who are not on insulin, must not be prescribed insulin within 60 days prior to screening ...

  7. High hemoglobin count When to see a doctor - Mayo Clinic

    A high hemoglobin (Hb or Hgb) count is a blood test result. It means that the level of a key protein in red blood cells called hemoglobin is higher than is ...

  8. Epicardial Delivery Of XC001 Gene Therapy To Promote Angiogenesis In CAD Patients Undergoing Treatment With CABG - Mayo Clinic

    Diabetic individuals with glycosylated hemoglobin (HbA1c) \> 9.5% or with active proliferative diabetic retinopathy. 8\. A history or evidence of human ...

  9. An Efficacy, Safety And Tolerability Study Of Ixmyelocel-T Administered Via Transendocardial Catheter-based Injections To Subjects With Heart Failure Due To Ischemic Dilated Cardiomyopathy (IDCM) - Mayo Clinic

    Hemoglobin A1c (HbA1c) ≥ 9% at screening; Diabetic subjects with uncontrolled or untreated proliferative retinopathy as determined by dilated eye exam ...

  10. A Trial Investigating the Safety, Tolerability and Effectiveness of TransCon PTH Administered Daily in Adults With Hypoparathyroidism - Mayo Clinic

    type 1 diabetes mellitus or poorly controlled type 2 diabetes mellitus (HbA1C > 9%;; documented HbA1C result drawn within 12 weeks prior to Screening is ...